Neudle.com: multiple sclerosis primary progressive

Differential
(Click to cross reference)

abducens nerve paralysis

abscess, intracerebral

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acute disseminated encephalomyelitis

acute necrotizing encephalitis

adenylate kinase 5 autoantibodies

adverse drug reaction

affect, flat

Alexanders disease

Alexanders disease, adult onset

amphiphysin antibodies

amyloid angiopathy, cerebral

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis, work up

aneurysm

aneurysm, cavernous sinus

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

anti Hu antibody

antibiotics

antihistamines

arterial dissection, aorta

arteriovenous malformation

arteriovenous malformation, cerebral

autoimmune cerebellar ataxia

Barkhof MR criteria for MS

behavioral disorder

Behcet's syndrome

bone marrow biopsy

bone marrow suppression

brain biopsy

brainstem, lesion of

brucellosis, nervous system involvement with

Brudzinski's sign

carbon monoxide poisoning

CAT scan, emission, abnormal

CAT scan, serial

cavernous sinus, syndrome

central nervous system, infection of

central pontine myelinolysis

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellar pontine angle tumor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral infarction

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular disease

cervical rib

cervical spine

cervical spondylosis

cervical spondylosis, differential diagnosis of

cervical spondylosis, misdiagnosis

chemotherapy, CNS treatment and complications with

Clinical Pathologic Conference(C.P.C.)

clinicoradiologic dissociation

collagen vascular disease

collapsin response mediator protein 5 IgG

complications

concentric sclerosis

confusion

contactin associated protein like 2 antibodies

controversies in neurology

cop 1

corpus callosum

corpus callosum, infarction of

corpus callosum, lesion of

corpus callosum, neoplasm of

cortical blindness

cost effectiveness

cranial neuropathy

cranial neuropathy, multiple

crying, pathologic

cryptococcal meningitis

cyclophosphamide

cyclosporine

cytomegalovirus infection

degenerative diseases of CNS

delirium

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dermatomyositis

diabetes mellitus

diarrhea

differential diagnosis

diffuse axonal injury

disability rating scale, neurological

disability, neurological

disease modifying agents

drug abuse

drug induced neurologic disorders

dysarthria

dysphagia

efficacy

electroencephalogram, abnormalities of

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

epidemiology of neurology

facial weakness, bilateral

gammaglobulin therapy, intravenous

genu of corpus callosum

glioblastoma multiforme(astrocytoma Gr.III)

glioma

gliomatosis cerebri

glutamic acid decarboxylase, antibody

gray matter

Guillain Barre syndrome

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes simplex virus

herpes virus infection

herpes zoster

heterochromia iridis

highly active antiretroviral therapy

hippocampal atrophy

hippocampus

hippocampus, hyperintense

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

Horner's syndrome

Horner's syndrome, etiologies of

human immunodeficiency virus type 1

hydrocephalus

hyperreflexia

hypertension

hypertensive encephalopathy

iatrogenic neurologic disorders

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

intellectual deterioration

interferon

interferon beta 1-a

interferon beta 1-b

intracerebral hemorrhage

Jakob-Creutzfeldt disease

JC virus

Kernig's sign

Klumpke palsy

laminectomy, cervical

laughing, pathologic

leucine rich glioma inactivated 1 antibodies

leukodystrophy

leukoencephalopathy

leukoencephalopathy, differential diagnosis

levamisole

level of consciousness, decreased

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

malformation, vascular, cerebral

malignancy screen

malignancy, occult

Marchiafava-Bignami disease

memory, defect of recent

memory, impairment of

mental status, abnormal

mesial temporal lobe

methotrexate

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

miosis

misdiagnosis

mitochondrial disease

mitoxantrone

monoclonal antibodies

mononeuropathy

mononeuropathy multiplex

motor neuron disease

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

multiple sclerosis, benign form of

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

myasthenia gravis, paraneoplastic

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic examination

neurologic practice

neurologic signs

neuromuscular junction

neuronal cell surface antigen

neuronopathy, sensory

neuropathology

neuropathy

neuropathy, paraneoplastic

neuropathy, sensory

NMDA antagonists

ocrelizumab

onconeural antibodies

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

otitis, neurologic complications with

palatal myoclonus

pancoast tumor

paraneoplastic cerebellar degeneration

paraparesis

paraparesis, spastic

paraproteinemia

paratrigeminal syndrome

peripheral nerve, lesion of

PLEDs, bilateral independent

PLEDs, etiology of

pleocytosis of cerebrospinal fluid

poliomyelitis

polyneuropathy

posterior inferior cerebellar artery syndrome

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

prosopagnosia

pseudobulbar palsy

psychological testing

psychomotor retardation

pulmonary nodules

pupil

pupil, abnormality in neurologic disorders

pyramidal tract dysfunction

quadriparesis

quadriplegia

quality of life

radiation therapy, CNS treatment and complications with

radiculitis

rapidly progressing neurologic illness

ReBUILD study

Red flags

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

shunt procedure, ventricular

shunt procedure, ventricular-complications of

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spasticity

speech disorder

speech, loss of

spinal cord, compression of

spondylosis

steroid

steroid therapy, CNS treatment and complications with

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

syringomyelia

systemic lupus erythematosus

tau protein

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

Thies's sign

thrombocytopenia

thyroiditis

tongue, impaired movements of

tonsillectomy

toxic encephalopathy

toxoplasmosis, acquired

toxoplasmosis, CNS

transient neurologic deficit

treatment of neurologic disorder

trigeminal neuropathy

trigeminal neuropathy, sensory

tuberculosis

tumor necrosis factor

tumor necrosis factor inhibitor

vaccination, neurologic complications with

vaccine

vasculitides

vasculopathy

vertebral-basilar insufficiency

viral infection

viral infection, CNS

viral infection, reactivation

visual evoked response

visual loss

Waldenstrom's macroglobulinemia

walking, difficulty with

white matter, dirty-appearing

workup

xerophthalmia

xerostomia

Showing articles 1150 to 1200 of 9318 << Previous Next >>

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Predictors of Fitness to Drive in People With Parkinson Disease
Neurol 69:1434-1441, Devos,H.,et al, 2007

The Incidence and Significance of Anti-Natalizumab Antibodies: Results from AFFIRM and SENTINEL
Neurol 69:1391-1403,1396, Calabresi,P.A.,et al, 2007

Recurrent Hemorrhagic Stroke in Children: A Population-Based Cohort Study
Stroke 38:2658-2662, Fullerton,H.J.,et al, 2007

Guidelines For Using Proton MR Spectroscopy in Multicenter Clinical MS Studies
Neurol 69:1942-1952, De Stefano,N.,et al, 2007

Long-Term Prognosis in Children With Neonatal Seizures: A Population-Based Study
Neurol 69:1816-1822, Ronen,G.M.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Mitoxantrone for Multiple Sclerosis Causing Acute Lymphoblastic Leukemia
Neurol 68:1630-1631, Cartwright,M.S.,et al, 2007

Clinicopath Conf,Lyme Disease of the Nervous System
NEJM 356:1561-1570, Case Record 11-2007, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Neurologic Complications of Gastric Bypass Surgery for Morbid Obesity
Neurol 68:1843-1850, Juhasz-Pocsine,K.,et al, 2007

Orthostatic Myoclonus: A Contributor to Gait Decline in Selected Elderly
Neurol 68:1826-1830, Glass,G.A.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007

NMO-IgG in the Diagnosis of Neuromyelitis Optica
Neurol 68:1076-1077, Jarius,S.,et al, 2007

Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS
Neurol 68:939-944, Cohen,J.A.,et a, 2007

Gray Matter Involvement in Multiple Sclerosis
Neurol 68:634-642, Pirko,I.,et al, 2007

Sexual Function in Men and Women With Neurological Disorders
Lancet 369:512-525, Rees,P.M.,et al, 2007

Neurodevelopment and Cognition in Children After Enterovirus 71 Infection
NEJM 356:1226-1234, Chang,L.-Y.,et al, 2007

Diagnosis and Treatment of Neuromyelitis Optica
The Neurologist 13:2-11, Wingerchuk,D.M., 2007

Bilateral Ocular Paralysis: Analysis of 31 Inpatients
Arch Neurol 64:178-180, Keane,J.R., 2007

Longitudinal Follow-Up of "Benign" Multiple Sclerosis at 20 Years
Neurol 68:496-500,480, Sayao,A-L.,et al, 2007

Multiple Sclerosis After Infectious Mononucleosis
Arch Neurol 64:72-75, Nielsen,T.R.,et al, 2007

A 34-Year-Old Man With Progressive Behavioral and Language Disturbance
Neurol 68:68-74, Miller,B.L.,et al, 2007

The Differential Diagnosis of Multiple Sclerosis
Neurologist 13:57-72, Rolak, L.A.,et al, 2007

Balos Concentric Sclerosis Presenting as a Stroke-Like Syndrome
Nat Clin Pract Neurol 3:349-354, Mowry,E.M.,et al, 2007

CSF Analysis in Patients With Sporadic CJD and Other Transmissible Spongiform Encephalopathies
Eur J Neurol 14:121-124, Green,A.,et al, 2007

Course of Cerebral Amyloid Angiopathy-Related Inflammation
Neurol 68:1411-1416, Kinnecom,C.,et al, 2007

Dementia and White-Matter Demyelination in Young Patient With Neurosyphilis
Lancet:368:2258, Brinar,V.V. &Habek,M., 2006

Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
JAMA 296:2832-2838, Munger,K.L.,et al, 2006

Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment
Neurol 67:1717-1718, Phillips,J.T.,et al, 2006

Treatment With Interferon beta-1b Delays Conversion to Clinically Definite and McDonald MS in Patients With Clinically Isolated Syndromes
Neurol 67:1242-1249, Kappos,L.,et al, 2006

Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006

Multiple Sclerosis: The Role of MR Imaging
AJNR 27:1165-1176, Ge,Y., 2006

A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages
Neurocrit Care 4:267-271, Finelli,P.F., 2006

Increase in Multiple Sclerosis Relapse Rate Following in vitro Fertilization
Neurol 66:1280-1281, Laplaud,D.-A.,et al, 2006

Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
JAMA 295:2483-2491,2535, Aoyama,H.,et al, 2006

Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
Neurologist 12:171-178, Cree,B., 2006

Tetanus Vaccination and Risk of Multiple Sclerosis: A Systematic Review
Neurol 67:212-215, Hernn,M.A.,et al, 2006

The Clinical Features, MRI Findings, and Outcome of Optic Neuritis in Children
Neurol 67:258-262, Wilejto,M.,et al, 2006

Premenstrual Multiple Sclerosis Pseudoexacerbations: Role of Body Temperature and Prevention With Aspirin
Arch Neurol 63:1005-1008, Wingerchuk,D.M. &Rodriguez,M., 2006

Significance of T2 Lesions in Multiple Sclerosis: A 13-Year Longitudinal Study
Ann Neurol 60:236-242, Rudick,R.A.,et al, 2006

Interferon beta-1a Treatment in Childhood and Juvenile-Onset Multiple Sclerosis
Neurol 67:511-513, Tenembaum,S.N. &Segura,M.J., 2006

Late-Onset Metachromatic Leukodystrophy: Genotype Strongly Influences Phenotype
Neurol 67:859-863, Rauschka,H.,et al, 2006

Obsessive-Compulsive Disorder
BMJ 333:424-429, Heyman,I.,et al, 2006

Does High-Field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis
AJNR 27:1794-1798, Wattjes,M.P.,et al, 2006

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006

Baseline MRI Predicts Future Attacks and Disability in Clinically Isolated Syndromes
Neurol 67:968-972, Tintore,M.,et al, 2006

Multiple Sclerosis with and without CSF Bands:Clinically Indistinguishable but Immunogenetically Distinct
Neurol 67:1062-1064, Imrell,K.,et al, 2006

The Tuberous Sclerosis Complex
NEJM 355:1345-1356, Crino,P.B.,et al, 2006

In Vivo Detection of Cortical Plaques by MR Imaging in Patients with Multiple Sclerosis
AJNR 27:2161-2167, Bagnato,F.,et al, 2006

Showing articles 1150 to 1200 of 9318 << Previous Next >>